Dystrophin is a tumor suppressor in human cancers with myogenic programs
2014 · Nature Genetics · 161 citations
https://doi.org/10.1038/ng.2974
A
Adrián Mariño‐Enríquez
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
223
Papers
6.6K
Citations
44
h-index
79
i10-index
Adrián Mariño‐Enríquez is an academic researcher from University College Dublin. The author has contributed to research in topics: Sarcoma Diagnosis and Treatment & Gastrointestinal Tumor Research and Treatment & Gastric Cancer Management and Outcomes. The author has an h-index of 44, co-authored 190 publications.
ORCID: 0000-0002-7680-9901Papers by this author
worksComplementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours
2019 · British Journal of Cancer · 159 citations
https://doi.org/10.1038/s41416-019-0389-6
Fusion of the <i>AHRR</i> and <i>NCOA2</i> genes through a recurrent translocation t(5;8)(p15;q13) in soft tissue angiofibroma results in upregulation of aryl hydrocarbon receptor target genes
2012 · Genes Chromosomes and Cancer · 149 citations
https://doi.org/10.1002/gcc.21939
MAX inactivation is an early event in GIST development that regulates p16 and cell proliferation
2017 · Nature Communications · 66 citations
https://doi.org/10.1038/ncomms14674
KIT ATP-Binding Pocket/Activation Loop Mutations in GI Stromal Tumor: Emerging Mechanisms of Kinase Inhibitor Escape
2024 · Journal of Clinical Oncology · 20 citations
https://doi.org/10.1200/jco.23.01197
Coordinated targeting of CK2 and KIT in gastrointestinal stromal tumours
2019 · British Journal of Cancer · 5 citations
https://doi.org/10.1038/s41416-019-0657-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat